Ro's investors include General Catalyst, FirstMark Capital, SignalFire, and Initialized Capital.
It belongs to a class of drugs called GLP-1 receptor agonists, which help regulate blood sugar levels by mimicking the effects of the natural hormone GLP-1
Convergent effects of gut Dysbiosis, IR, and hyperandrogenemia on endometrial dysfunction While gut dysbiosis, IR, and HA originate from distinct physiological systems, they converge on a common final pathway: the generation of excessive ROS that overwhelms endometrial defense [50, 72]
However, its important to note: Weight management can be a valuable secondary outcome for people with T2DM, as it often improves insulin sensitivity, lowers cardiovascular risk, and enhances overall metabolic health 4 , 10
That third pathway drives increased energy expenditure, not just reduced appetite